mDR Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for mDR.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Electronic earnings growth	25.4%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

mDR Limited's (SGX:Y3D) Price Is Out Of Tune With Revenues

Oct 04

mDR Limited (SGX:Y3D) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Jun 21

We Like These Underlying Return On Capital Trends At mDR (SGX:Y3D)

May 21

Risks To Shareholder Returns Are Elevated At These Prices For mDR Limited (SGX:Y3D)

Apr 09

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as mDR has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SGX:Y3D - Analysts future estimates and past financials data (SGD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2024	243	-25	14	14	N/A
3/31/2024	230	-34	11	11	N/A
12/31/2023	216	-42	8	9	N/A
9/30/2023	201	-23	6	7	N/A
6/30/2023	186	-4	4	5	N/A
3/31/2023	181	2	4	5	N/A
12/31/2022	175	9	4	5	N/A
9/30/2022	176	4	10	11	N/A
6/30/2022	176	-1	17	17	N/A
3/31/2022	183	1	20	21	N/A
12/31/2021	189	4	23	24	N/A
9/30/2021	196	-4	17	17	N/A
6/30/2021	203	-12	10	10	N/A
3/31/2021	198	-12	18	19	N/A
12/31/2020	194	-13	26	27	N/A
9/30/2020	216	-10	26	26	N/A
6/30/2020	236	-2	26	27	N/A
3/31/2020	259	0	13	14	N/A
12/31/2019	286	1	5	6	N/A
9/30/2019	282	6	-8	-7	N/A
6/30/2019	276	4	-4	-3	N/A
3/31/2019	270	3	-11	-9	N/A
12/31/2018	265	3	-12	-11	N/A
9/30/2018	266	3	-4	-3	N/A
6/30/2018	264	4	-6	-4	N/A
3/31/2018	277	5	N/A	1	N/A
12/31/2017	275	5	N/A	3	N/A
9/30/2017	273	5	N/A	6	N/A
6/30/2017	270	5	N/A	10	N/A
3/31/2017	260	4	N/A	8	N/A
12/31/2016	263	3	N/A	4	N/A
9/30/2016	278	3	N/A	3	N/A
6/30/2016	294	3	N/A	5	N/A
3/31/2016	310	3	N/A	8	N/A
12/31/2015	319	4	N/A	4	N/A
9/30/2015	330	-4	N/A	8	N/A
6/30/2015	324	-8	N/A	3	N/A
3/31/2015	312	-9	N/A	-4	N/A
12/31/2014	322	-10	N/A	0	N/A
9/30/2014	330	-2	N/A	2	N/A
6/30/2014	339	2	N/A	-4	N/A
3/31/2014	352	3	N/A	5	N/A
12/31/2013	348	3	N/A	4	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if Y3D's forecast earnings growth is above the savings rate (2.2%).

Earnings vs Market: Insufficient data to determine if Y3D's earnings are forecast to grow faster than the SG market

High Growth Earnings: Insufficient data to determine if Y3D's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if Y3D's revenue is forecast to grow faster than the SG market.

High Growth Revenue: Insufficient data to determine if Y3D's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if Y3D's Return on Equity is forecast to be high in 3 years time

mDR Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

mDR Limited's (SGX:Y3D) Price Is Out Of Tune With Revenues

mDR Limited (SGX:Y3D) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

New major risk - Share price stability

We Like These Underlying Return On Capital Trends At mDR (SGX:Y3D)

Full year 2023 earnings released: S$0.049 loss per share (vs S$0.011 profit in FY 2022)

mDR Limited, Annual General Meeting, Apr 29, 2024

Risks To Shareholder Returns Are Elevated At These Prices For mDR Limited (SGX:Y3D)

mDR Limited Approves Promotion of Cindy Tham Yen Yi as Chief Commercial Officer

New minor risk - Financial data availability

A Look At The Intrinsic Value Of mDR Limited (SGX:Y3D)

Now 23% overvalued

mDR Limited to Report Fiscal Year 2023 Results on Feb 28, 2024

Insufficient new directors

First half 2023 earnings released: S$0.019 loss per share (vs S$0.004 loss in 1H 2022)

New major risk - Dividend sustainability

New minor risk - Share price stability

mDR Limited to Report First Half, 2023 Results on Aug 14, 2023

mDR (SGX:Y3D) Has A Pretty Healthy Balance Sheet

Full year 2022 earnings released: EPS: S$0.011 (vs S$0.005 in FY 2021)

mDR Limited to Report Fiscal Year 2022 Results on Feb 28, 2023

The Returns On Capital At mDR (SGX:Y3D) Don't Inspire Confidence

Does mDR (SGX:Y3D) Have A Healthy Balance Sheet?

mDR Limited Approves Final Tax Exempt (One-Tier) Dividend for the Year Ended 31 December 2022

Full year 2021 earnings released: EPS: S$0.006 (vs S$0.016 loss in FY 2020)

mDR Limited, Annual General Meeting, Jul 27, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

mDR Limited, Annual General Meeting, Apr 29, 2022

mDR Limited to Report Fiscal Year 2021 Results on Feb 28, 2022

Is mDR (SGX:Y3D) A Risky Investment?

Full year 2020 earnings released: S$0.016 loss per share (vs S$0.002 profit in FY 2019)

Full year 2020 earnings released

Does mDR (SGX:Y3D) Have The Makings Of A Multi-Bagger?

mDR Limited to Report Second Half, 2020 Results on Feb 26, 2021

Is mDR (SGX:A27) A Risky Investment?

Will the Promising Trends At mDR (SGX:Y3D) Continue?

mDR Limited Appoints Ong Siow Fong as Non-Executive Independent Director Nominating Committee Member Remuneration Committee Member

First half earnings released

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies